开立医疗(300633)披露2025年股票期权与限制性股票激励计划之股票期权授予登记完成公告,10月30日股价下跌5.45%

Core Points - The stock of Kaili Medical (300633) closed at 28.61 yuan on October 30, 2025, down 5.45% from the previous trading day, with a total market capitalization of 12.38 billion yuan [1] - The company announced the completion of the stock option grant registration for its 2025 stock option and restricted stock incentive plan, with a total of 3.9678 million stock options granted to 306 incentive recipients [1] - The exercise price for the stock options is set at 31.86 yuan per option, with a maximum validity period of 60 months and a waiting period of 12, 24, 36, and 48 months for different tranches [1] - The performance assessment targets are based on a net profit of 136.49 million yuan for 2024, requiring net profit growth rates of no less than 30%, 70%, 150%, and 260% for the years 2025 to 2028 [1] Summary by Category Stock Performance - The stock opened at 30.14 yuan, reached a high of 30.14 yuan, and a low of 28.54 yuan, with a trading volume of 390 million yuan and a turnover rate of 3.1% [1] Incentive Plan - The stock options are referred to as "Kaili JLC1" with the registration completed on October 29, 2025 [1] - The authorization date for the options was October 16, 2025, and the options will be exercised in four tranches, each accounting for 25% of the total options granted [1] Performance Targets - The performance targets for the incentive plan are ambitious, with significant growth rates required over the next four years [1]